Literature DB >> 2854245

Neurochemical effects of the synthetic ACTH4-9-analog Hoe 427 (Ebiratide) in rat brain.

G Wiemer1, H J Gerhards, F J Hock, P Usinger, W Von Rechenberg, R Geiger.   

Abstract

The ACTH4-9-analog Hoe 427 systemically injected in a dose range from 0.01-10 micrograms/kg caused a fall in acetylcholine (ACh) content in different brain areas of the rat. This effect occurred 0.5 hour after a single administration and lasted up to 24 hours. The decrease in ACh content induced by Hoe 427 was more pronounced when the animals were pretreated with dexamethasone (over 7 days 1 mg/kg SC, daily). Coadministration of the choline uptake inhibitor hemicholinium-3 (HC-3) and Hoe 427 potentiated the decrease in ACh content induced by HC-3. In the same dose range Hoe 427 acutely evoked an increase of the activity of the enzyme choline acetyltransferase as well as an elevation of brain cyclic GMP content. These data indicate that Hoe 427 enhances ACh metabolism in rat brain after systemic administration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854245     DOI: 10.1016/0196-9781(88)90093-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans.

Authors:  J Born; W Kern; R Pietrowsky; W Sittig; H L Fehm
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The neurotrophic effects of ebiratide, an analog of ACTH4-9, on cultured septal cells and aged rats.

Authors:  T Matsumoto; S Tsuda; S Nakamura
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.

Authors:  T Terasaki; S Takakuwa; A Saheki; S Moritani; T Shimura; S Tabata; A Tsuji
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.